Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
Lisa Belfiore(University of Wollongong), Kara L. Vine(University of Wollongong), Kristofer J. Thurecht(The University of Queensland), Marie Ranson(University of Wollongong), Darren N. Saunders(Garvan Institute of Medical Research), Gert Storm(Yong In University)
Cited by 297
Related Papers
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269